Docstoc

Aarkstore Poisoning – Pipeline Review, H1 2012

Document Sample
Aarkstore Poisoning – Pipeline Review, H1 2012 Powered By Docstoc
					Poisoning – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, Poisoning Pipeline Review, H1 2012, provides an overview of the
Poisoning therapeutic pipeline. This report provides information on the therapeutic development
for Poisoning, complete with latest updates, and special features on late-stage and discontinued
projects. It also reviews key players involved in the therapeutic development for Poisoning.
Poisoning Pipeline Review, H1 2012 is built using data and information sourced from Global
Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific
third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.

Scope

A snapshot of the global therapeutic scenario for Poisoning.
A review of the Poisoning products under development by companies and universities/research
institutes based on information derived from company and industry-specific sources.
Coverage of products based on various stages of development ranging from discovery till
registration stages.
A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Coverage of the Poisoning pipeline on the basis of route of administration and molecule type.
Profiles of late-stage pipeline products featuring sections on product description, mechanism of
action and research & development progress.
Key discontinued pipeline projects.
Latest news and deals relating to the products.

Reasons to buy

Identify and understand important and diverse types of therapeutics under development for
Poisoning.
Identify emerging players with potentially strong product portfolio and design effective counter-
strategies to gain competitive advantage.
Plan mergers and acquisitions effectively by identifying players with the most promising
pipeline.
Devise corrective measures for pipeline projects by understanding Poisoning pipeline depth and
focus of Poisoning therapeutics.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners
with the most attractive projects to enhance and expand business potential and scope.
Modify the therapeutic portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline.

For more information, please visit :-

http://www.aarkstore.com/reports/Poisoning-Pipeline-Review-H1-2012-188535.html

Marketing Team

Aarkstore Enterprise

Phone:08149852585

Email:enquiry@aarkstore.com

URL:www.aarkstore.com

http://twitter.com/aarkstoredotcom

http://in.linkedin.com/in/aarkstore

http://www.facebook.com/aarkstoreenterprise

More Related Reports :-

Coronary Stenosis – Pipeline Review, H1 2012
Hypoglycemia – Pipeline Review, H1 2012
Nasopharyngitis (Common Cold) – Pipeline Review, H1 2012
AIDS Associated Dementia – Pipeline Review, H1 2012
Open-Angle Glaucoma – Pipeline Review, H1 2012
Myocardial Ischemia – Pipeline Review, H1 2012
Primary Immune Deficiency (PID) – Pipeline Review, H1 2012
Vancomycin-Resistant Enterococcus Faecium Infections – Pipeline Review, H1 2012
Intra Dialytic Hypotension – Pipeline Review, H1 2012
Poisoning – Pipeline Review, H1 2012
Spinal Cord Injury – Pipeline Review, H1 2012
Respiratory Distress Syndrome – Pipeline Review, H1 2012

				
DOCUMENT INFO
Description: Aarkstore announce a new report "Poisoning – Pipeline Review, H1 2012 " through its vast collection of market research report